<!DOCTYPE html>
<html lang="en">

<head>
	<!-- Global site tag (gtag.js) - Google Analytics -->
	<script async src="https://www.googletagmanager.com/gtag/js?id=UA-1734385-15"></script>
	<script>
		window.dataLayer = window.dataLayer || [];
		function gtag() { dataLayer.push(arguments); }
		gtag('js', new Date());

		gtag('config', 'UA-1734385-15');
	</script>
	<!-- Google tag (gtag.js) -->
	<script async src="https://www.googletagmanager.com/gtag/js?id=G-PDVVHXRDE6"></script>
	<script>
		window.dataLayer = window.dataLayer || [];
		function gtag() { dataLayer.push(arguments); }
		gtag('js', new Date());

		gtag('config', 'G-PDVVHXRDE6');
	</script>

	<meta charset="utf-8" />
	<meta name="version" content="v10.15.3" />
	<meta name="viewport" content="width=device-width, initial-scale=1.0">
	<link rel="shortcut icon" href="https://www.law.cornell.edu/sites/www.law.cornell.edu/files/favicon_0.ico"
		type="image/vnd.microsoft.icon" />
	<link rel="canonical" href="https://www.law.cornell.edu/uscode/text/21/351">

	<meta property="og:site_name" content="LII / Legal Information Institute" />
	<meta property="og:type" content="website" />
	<meta property="og:url" content="https://www.law.cornell.edu/uscode/text/21/351" />
	<meta property="og:title" content="21 U.S. Code &sect; 351 - Adulterated drugs and devices" />
	<meta property="og:image" content="https://www.law.cornell.edu/images/liibracketlogo.gif" />
	
	<meta name="twitter:card" content="US Code - Title 21 > CHAPTER 9 > SUBCHAPTER V > Part A > § 351" />
	<meta name="twitter:site" content="@LIICornell" />
	<meta name="twitter:url" content="https://www.law.cornell.edu/uscode/text/21/351" />
	<meta name="twitter:title" content="21 U.S. Code &sect; 351 - Adulterated drugs and devices" />
	<meta name="twitter:image" content="https://www.law.cornell.edu/images/liibracketlogo.gif" />
	<meta name="dcterms.title" content="21 U.S. Code &sect; 351 - Adulterated drugs and devices" />


	<title>21 U.S. Code &sect; 351 - Adulterated drugs and devices | U.S. Code | US Law | LII / Legal Information Institute</title>
	

	<!-- schema.org metadata -->
	<script type="application/ld+json">
		{"@context": "http://schema.org", "@graph": [{"@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "item": {"@id": "https://www.law.cornell.edu", "name": "LII"}}, {"@type": "ListItem", "position": 2, "item": {"@id": "https://www.law.cornell.edu/uscode/text", "name": "U.S. Code"}}, {"@type": "ListItem", "position": 3, "item": {"@id": "https://www.law.cornell.edu/uscode/text/21", "name": "Title 21"}}, {"@type": "ListItem", "position": 4, "item": {"@id": "https://www.law.cornell.edu/uscode/text/21/chapter-9", "name": "CHAPTER 9"}}, {"@type": "ListItem", "position": 5, "item": {"@id": "https://www.law.cornell.edu/uscode/text/21/chapter-9/subchapter-V", "name": "SUBCHAPTER V"}}, {"@type": "ListItem", "position": 6, "item": {"@id": "https://www.law.cornell.edu/uscode/text/21/chapter-9/subchapter-V/part-A", "name": "Part A"}}, {"@type": "ListItem", "position": 7, "item": {"@id": "https://www.law.cornell.edu/uscode/text/21/351", "name": "\u00a7\u202f351"}}]}, {"@type": "WebSite", "url": "https://www.law.cornell.edu/uscode/text/21/351", "name": "\u00a7\u202f351", "author": {"@type": "Organization", "name": "Office of the Law Revision Counsel", "url": "http://uscode.house.gov/about_office.xhtml"}, "description": "US Code - Title 21 > CHAPTER 9 > SUBCHAPTER V > Part A > \u00a7\u202f351", "publisher": {"@type": "Organization", "name": "LII / Legal Information Institute", "url": "https://www.law.cornell.edu"}}]}
	</script>
	<!-- /schema.org -->

	<!-- API url -->
	<script>
		SEARCH_URL = 'https://api.law.cornell.edu/lii/search';
	</script>

	<script src="/js/jquery-3.6.1.min.js"></script>
	<script src="/js/js.cookie.min.js"></script>
	<script src="/js/bootstrap.min.js"></script>
	<link rel="stylesheet" href="/fonts/open-sans.css">

	
	<link rel="stylesheet" type="text/css" href="/staticsite_styles/lii_stylenator_v48.min.css" />
	 

	

	<!-- include adcode -->
	<script type='text/javascript'>
		!function (a) { var b = /iPhone/i, c = /iPod/i, d = /iPad/i, e = /(?=.*\bAndroid\b)(?=.*\bMobile\b)/i, f = /Android/i, g = /(?=.*\bAndroid\b)(?=.*\bSD4930UR\b)/i, h = /(?=.*\bAndroid\b)(?=.*\b(?:KFOT|KFTT|KFJWI|KFJWA|KFSOWI|KFTHWI|KFTHWA|KFAPWI|KFAPWA|KFARWI|KFASWI|KFSAWI|KFSAWA)\b)/i, i = /IEMobile/i, j = /(?=.*\bWindows\b)(?=.*\bARM\b)/i, k = /BlackBerry/i, l = /BB10/i, m = /Opera Mini/i, n = /(CriOS|Chrome)(?=.*\bMobile\b)/i, o = /(?=.*\bFirefox\b)(?=.*\bMobile\b)/i, p = new RegExp('(?:Nexus 7|BNTV250|Kindle Fire|Silk|GT-P1000)', 'i'), q = function (a, b) { return a.test(b) }, r = function (a) { var r = a || navigator.userAgent, s = r.split('[FBAN'); return 'undefined' != typeof s[1] && (r = s[0]), s = r.split('Twitter'), 'undefined' != typeof s[1] && (r = s[0]), this.apple = { phone: q(b, r), ipod: q(c, r), tablet: !q(b, r) && q(d, r), device: q(b, r) || q(c, r) || q(d, r) }, this.amazon = { phone: q(g, r), tablet: !q(g, r) && q(h, r), device: q(g, r) || q(h, r) }, this.android = { phone: q(g, r) || q(e, r), tablet: !q(g, r) && !q(e, r) && (q(h, r) || q(f, r)), device: q(g, r) || q(h, r) || q(e, r) || q(f, r) }, this.windows = { phone: q(i, r), tablet: q(j, r), device: q(i, r) || q(j, r) }, this.other = { blackberry: q(k, r), blackberry10: q(l, r), opera: q(m, r), firefox: q(o, r), chrome: q(n, r), device: q(k, r) || q(l, r) || q(m, r) || q(o, r) || q(n, r) }, this.seven_inch = q(p, r), this.any = this.apple.device || this.android.device || this.windows.device || this.other.device || this.seven_inch, this.phone = this.apple.phone || this.android.phone || this.windows.phone, this.tablet = this.apple.tablet || this.android.tablet || this.windows.tablet, 'undefined' == typeof window ? this : void 0 }, s = function () { var a = new r; return a.Class = r, a }; 'undefined' != typeof module && module.exports && 'undefined' == typeof window ? module.exports = r : 'undefined' != typeof module && module.exports && 'undefined' != typeof window ? module.exports = s() : 'function' == typeof define && define.amd ? define('isMobile', [], a.isMobile = s()) : a.isMobile = s() }(this);
	</script>

	<!-- mobile: vignettes and page-level -->
	<script async src='//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js'>
	</script>
	<script>
		(adsbygoogle = window.adsbygoogle || []).push({
			google_ad_client: 'ca-pub-6351434937294517',
			enable_page_level_ads: true,

		});
	</script>

	<!-- adsense -->
	<script type='text/javascript'>
		var googletag = googletag || {};
		googletag.cmd = googletag.cmd || [];
		(function () {
			var gads = document.createElement('script');
			gads.async = true;
			gads.type = 'text/javascript';
			var useSSL = 'https:' == document.location.protocol;
			gads.src = (useSSL ? 'https:' : 'http:') +
				'//www.googletagservices.com/tag/js/gpt.js';
			var node = document.getElementsByTagName('script')[0];
			node.parentNode.insertBefore(gads, node);
		})();
	</script>

	<script type='text/javascript'>
		function makeDefs() {
			var width = window.innerWidth || document.documentElement.clientWidth;
			if (width >= 1200) {
				var topsize = '[336,280]';
				var midsize = '[[1,1],[336,280]]';
				var bottomsize = '[[2,1],[728,90]]';
				var sponsorcaptionsize = '[[3,1],[336,15]]';
			}
			else if ((width >= 992) && (width < 1199)) {
				var topsize = '[336,280]';
				var midsize = '[[1,1],[336,280]]';
				var bottomsize = '[[2,1],[468,60]]';
				var sponsorcaptionsize = '[[3,1],[336,15]]';
			}
			else if ((width >= 768) && (width < 992)) {
				var topsize = '[300,250]';
				var midsize = '[[1,1],[300,250]]';
				var bottomsize = '[[2,1],[320,100],[320,50]]';
				var sponsorcaptionsize = '[[3,1],[300,15]]';
			}
			else if ((width >= 576) && (width < 768)) {
				var topsize = '[180,150]';
				var midsize = '[[1,1],[180,150]]';
				var bottomsize = '[[2,1],[320,100],[320,50]]';
				var sponsorcaptionsize = '[[3,1],[180,15]]';
			}
			else if ((width >= 360) && (width < 576)) {
				var topsize = '[336,280]';
				var midsize = '[[1,1],[336,280]]';
				var bottomsize = '[[2,1],[468,60]]';
				var sponsorcaptionsize = '[[3,1],[336,15]]';
			}
			else {
				var topsize = '[300,250]';
				var midsize = '[[1,1],[300,250]]';
				var bottomsize = '[[2,1],[300,250],[320,100],[320,50]]';
				var sponsorcaptionsize = '[[3,1],[300,15]]';
			}

			var topdefp1 = 'googletag.defineSlot(';
			var topdefp2 = "'/1519273/USC_ROC_TopRight_300x250', ".concat(topsize, ',');
			var topdef = topdefp1.concat(topdefp2, '\'', 'div-gpt-ad-top', '\'', ').addService(googletag.pubads());   ');

			var middefp1 = 'googletag.defineSlot(';
			var middefp2 = "'/1519273/USC_ROC_MidRight_300x250', ".concat(midsize, ',');
			var middef = middefp1.concat(middefp2, '\'', 'div-gpt-ad-middle', '\'', ').addService(googletag.pubads());   ');

			var bottomdefp1 = 'googletag.defineSlot(';
			var bottomdefp2 = "'/1519273/USC_ROC_Footer_728x90', ".concat(bottomsize, ',');
			var bottomdef = bottomdefp1.concat(bottomdefp2, '\'', 'div-gpt-ad-bottom', '\'', ').addService(googletag.pubads());   ');

			var sponsorcaptiondefp1 = 'googletag.defineSlot(';
			var sponsorcaptiondefp2 = "'/1519273/USC_ROC_SponsorCaption', ".concat(sponsorcaptionsize, ',');
			var sponsorcaptiondef = sponsorcaptiondefp1.concat(sponsorcaptiondefp2, '\'', 'div-gpt-ad-sponsorcaption', '\'', ').addService(googletag.pubads());   ');

			var defs = topdef + middef + bottomdef + sponsorcaptiondef
			return defs;

		};



		googletag.cmd.push(function () {
			{
				mydefs = makeDefs();
				eval(mydefs);
			};

			googletag.pubads().enableSingleRequest();
			googletag.enableServices();
		});
			//-->
	</script>
	<!-- /adsense -->
	<!-- /include adcode -->

	
	<script src="https://justatic.com/v/20160725b/shared/js/widgets/find-a-lawyer.js"></script>
	

</head>



<body>
	

	
<div id="liisurveymodal" class="modal fade bs-example-modal-lg" tabindex="-1" role="dialog" aria-labelledby="liisurveymodal" aria-hidden="true">
    <div class="modal-dialog modal-lg">
        <div class="modal-content">
                <div class="modal-title-box">Please help us improve our site!</div>	
            <div class="modal-header">
                <button type="button" class="close" onclick="snooze_survey()" data-dismiss="modal">&times;</button>
            </div>			
            <div class="modal-body">	  
                <iframe title="Survey Frame" class="survey-content" id="iframeHolder"></iframe>
            </div>		
            <div class="modal-footer">
                <a href="#" class="btn btn-primary" class="close" data-dismiss="modal" onclick="snooze_survey()">No thank you</a>
            </div>
        </div>
    </div>
</div>


	<header id="conannav" class="navbar navbar-fixed-top active">
		<a href="#content" class="skip">Skip to main content</a>

		<div id="cu-identity">
			<div class="container-fluid">
				<a href="https://www.cornell.edu" id="insignialink" title="Cornell University">
					<img class="img-responsive"
						src="https://www.law.cornell.edu/sites/all/themes/liizenboot/images/insignia.gif"
						alt="Cornell University insignia" />
				</a>
				<a href="https://www.lawschool.cornell.edu/" id="clslink" title="Cornell Law School">Cornell Law
					School</a>
				<a href="https://www.cornell.edu/search/" id="cusearch" title="Search Cornell University">Search
					Cornell</a>
			</div>
		</div>

		<div id="lii-identity" class="col-12 identity-header">
			<div id="liiheader" class="container-fluid">
				<nav id="liiallnav" class="navbar" aria-label="Main">
					<div id="liibanner" class="navbar-header">
						<button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#liinav"
							href="#liinav">
							<span class="sr-only">Toggle navigation</span>
							<span class="icon-bar"></span>
							<span class="icon-bar"></span>
							<span class="icon-bar"></span>
						</button>
						<div id="liilogodiv">
							<a id="liilogo" class="navbar-brand" href="/" aria-label="lii logo"></a>
						</div>
						<div class="navbar-right" id="liinavbarstuff">
							
							<button id="survey" class="btn btn-primary icon-pencil icon-white"
								style="display: none; margin-bottom: 10px; margin-top:-20px; height: 42px">Please help
								us improve our site!</button>

							<div id="liidonatewrap">
								<a id="liidonate" class="navbar-link mdblueinv" href="/donate"
									aria-label="Donate to LII">
									<span class="glyphicon glyphicon-gift"></span>
									<span class="gltxt">Support Us!</span>
								</a>
							</div>

							<div id="liisearchlinkwrap">
								<a id="liisearchlink" href="#" class="navbar-link cured" aria-label="Search LII">
									<span class="glyphicon glyphicon-search"></span>
									<span class="gltxt">Search</span>
								</a>
							</div>

							<div id="liisearch" href="#">
								<div class="input-group" id="adv-search" role="search">
									<input label="Enter the terms you wish to search for." placeholder="Search"
										class="form-control form-text" type="text" id="edit-keys" name="keys" value=""
										list="autocomplete_list" aria-label="Enter search terms text box">
									<datalist id="autocomplete_list">
									</datalist>
									<div class="input-group-btn">
										<div class="btn-group" role="group" aria-label="Filter and search buttons">
											<button type="button" class="btn btn-primary" onclick="findNowClickEvent()"
												aria-label="Find now"><span class="glyphicon glyphicon-search"
													aria-hidden="true" role="button"></span></button>
										</div>
									</div>
								</div>
							</div>
						</div>

						<div id="liinav" class="collapse navbar-collapse">
							<ul id="liiheadernav" class="nav navbar-nav" role="menubar" aria-hidden="false">
								<li role="menuitem" aria-haspopup="true" class="menu-item dropdown dropdown-submenu">
									<a href="/lii/about/about_lii" class="dropdown-toggle" data-toggle="dropdown"
										aria-expanded="false">About
										LII</a>
									<ul role="menu" aria-hidden="true" class="dropdown-menu sub-menu">
										<li role="menuitem">
											<a href="/lii/about/who_we_are">Who We Are</a>
										</li>
										<li role="menuitem">
											<a href="/lii/about/what_we_do">What We Do</a>
										</li>
										<li role="menuitem">
											<a href="/lii/about/who_pays_for_this">Who Pays For This</a>
										</li>
										<li role="menuitem">
											<a href="/lii/about/contact_us">Contact Us</a>
										</li>
									</ul>
								</li>
								<li role="menuitem" aria-haspopup="true" class="menu-item dropdown dropdown-submenu">
									<a href="/lii/get_the_law" class="dropdown-toggle" data-toggle="dropdown"
										aria-expanded="false">Get the
										law</a>
									<ul role="menu" aria-hidden="true" class="dropdown-menu sub-menu">
										<li role="menuitem">
											<a title="U.S. Constitution" href="/constitution">Constitution</a>
										</li>
										<li role="menuitem">
											<a title="Supreme Court" href="/supremecourt/text/home">Supreme Court</a>
										</li>
										<li role="menuitem">
											<a title="U.S. Code" href="/uscode/text">U.S. Code</a>
										</li>
										<li role="menuitem">
											<a title="C.F.R." href="/cfr/text">CFR</a>
										</li>
										<li role="menuitem" aria-haspopup="true"
											class="menu-item dropdown dropdown-submenu">
											<a title="Federal Rules" href="/rules" class="dropdown-toggle"
												data-toggle="dropdown" aria-expanded="false">Federal Rules</a>
											<ul role="menu" aria-hidden="true" class="dropdown-menu submenu-menu">
												<li role="menuitem">
													<a href="/rules/frap">Federal Rules of Appellate Procedure</a>
												</li>
												<li role="menuitem">
													<a href="/rules/frcp">Federal Rules of Civil Procedure</a>
												</li>
												<li role="menuitem">
													<a href="/rules/frcrmp">Federal Rules of Criminal Procedure</a>
												</li>
												<li role="menuitem">
													<a href="/rules/fre">Federal Rules of Evidence</a>
												</li>
												<li role="menuitem">
													<a href="/rules/frbp">Federal Rules of Bankruptcy Procedure</a>
												</li>
											</ul>
										</li>
										<li role="menuitem">
											<a title="U.C.C." href="/ucc">U.C.C.</a>
										</li>
										<li aria-haspopup="true" class="menu-item dropdown dropdown-submenu">
											<a title="Law by jurisdiction" href="#" class="dropdown-toggle"
												data-toggle="dropdown" aria-expanded="false">Law by jurisdiction</a>
											<ul role="menu" class="dropdown-menu submenu-menu">
												<li role="menuitem">
													<a href="/states">State law</a>
												</li>
												<li role="menuitem">
													<a href="/uniform">Uniform laws</a>
												</li>
												<li role="menuitem">
													<a href="/federal">Federal law</a>
												</li>
												<li role="menuitem">
													<a href="/world">World law</a>
												</li>
											</ul>
										</li>
									</ul>
								</li>
								<li role="menuitem">
									<a href="https://lawyers.law.cornell.edu/">Lawyer directory</a>
								</li>
								<li role="menuitem" class="menu-item dropdown dropdown-submenu">
									<a href="/wex" class="dropdown-toggle" data-toggle="dropdown"
										aria-expanded="false">Legal encyclopedia</a>
									<ul role="menu" class="dropdown-menu sub-menu">
										<li role="menuitem">
											<a href="/wex/category/business_law">Business law</a>
										</li>
										<li role="menuitem">
											<a href="/wex/category/constitutional_law">Constitutional law</a>
										</li>
										<li role="menuitem">
											<a href="/wex/category/criminal_law_and_procedure">Criminal law</a>
										</li>
										<li role="menuitem">
											<a href="/wex/category/family_law">Family law</a>
										</li>
										<li role="menuitem">
											<a href="/wex/category/employment_law">Employment law</a>
										</li>
										<li role="menuitem">
											<a href="/wex/category/money_and_financial_problems">Money and Finances</a>
										</li>

										<li role="menuitem">
											<a href="/wex/wex_articles">More...</a>
										</li>
									</ul>
								</li>
								<li role="menuitem" class="menu-item dropdown dropdown-submenu">
									<a href="/lii/help_out" class="dropdown-toggle" data-toggle="dropdown"
										aria-expanded="false">Help out</a>
									<ul role="menu" class="dropdown-menu sub-menu">
										<li role="menuitem" aria-hidden="true">
											<a href="/donate">Give</a>
										</li>
										<li role="menuitem" aria-hidden="true">
											<a href="/lii/help_out/sponsor">Sponsor</a>
										</li>
										<li role="menuitem">
											<a href="/lii/help_out/advertise">Advertise</a>
										</li>
										<li role="menuitem">
											<a href="/lii/help_out/create">Create</a>
										</li>
										<li role="menuitem">
											<a href="/lii/help_out/promote">Promote</a>
										</li>
										<li role="menuitem">
											<a href="/lii/help_out/join_directory">Join Lawyer Directory</a>
										</li>
									</ul>
								</li>
							</ul>
							<ul id="liinavsoc" class="nav navbar-nav navbar-right">
								<li>
									
									<div class="addthis_horizontal_follow_toolbox"></div>
								</li>
							</ul>
						</div>
					</div>
					
				</nav>
			</div>
		</div>
		
		
	</header>
	<br><br>
	
	<div id="breadcrumb" class="container-fluid">
		<div class="row">
			<div class="navbar-header">
				<nav aria-label="breadcrumb" class="bc-icons-2">
					<ol class="breadcrumb">
						
						
						
						<li class="breadcrumb-item"><a href="/">LII</a></li>
						
						 
						
						<li class="breadcrumb-item" aria-label="U.S. Code table of contents"><a
								href="/uscode/text">U.S. Code</a></li>
						
						 
						
						<li class="breadcrumb-item"><a href="/uscode/text/21">Title 21</a></li>
						
						 
						
						<li class="breadcrumb-item"><a href="/uscode/text/21/chapter-9">CHAPTER 9</a></li>
						
						 
						
						<li class="breadcrumb-item"><a href="/uscode/text/21/chapter-9/subchapter-V">SUBCHAPTER V</a></li>
						
						 
						
						<li class="breadcrumb-item"><a href="/uscode/text/21/chapter-9/subchapter-V/part-A">Part A</a></li>
						
						 
						
						<li class="breadcrumb-item breadcrumb-last">§ 351</li>
						
						 
					</ol>
				</nav>
			</div>
		</div>
	</div>
	

	<main id="main" class="container-fluid">
		<div id="content" class="col-sm-8">
			<div class="pagewrapper">
				<div class="container-fluid">
					<div class="row">
						
						<div title="Definitions Frame"></div>
						
<small id="titleHelp" class="form-text">Quick search by citation:</small>
<form class="form-inline">
    <div class="form-group mb-2">
        <label for="titleinput">Title</label>
        <input type="number" name="quicksearch" class="form-control" id="titleinput" aria-describedby="titleHelp" placeholder="enter title"
            title="US Code Title number" type="number" value="">
    </div>
    <div class="form-group mx-sm-3 mb-2">
        <label for="sectioninput">Section</label>
        <input type="text" name="quicksearch" class="form-control" id="sectioninput" pattern="[A-Za-z0-9]+" placeholder="section"
            title="US Code Section number" value="">
    </div>
    <button id="RedirectUSC" type="submit" class="btn btn-primary">Go!</button>
</form>

						
						
						<h1 class="title" id="page_title"> 21 U.S. Code § 351 - Adulterated drugs and devices </h1>
<div class="tabbable-panel">
<div class="tabbable-line">
<ul class="nav nav-tabs ">
<li class="active">
<a data-toggle="tab" href="#tab_default_1">
                        U.S. Code </a>
</li>
<li>
<a data-toggle="tab" href="#tab_default_2">
                        Notes </a>
</li>
<li>
<a data-toggle="tab" href="#tab_default_3">
                    			
                        Authorities (CFR)
                     
                </a>
</li>
</ul>
<div class="tab-content">
<div id="prevnext">
                    prev | <a href="/uscode/text/21/352" title=" Misbranded drugs and devices">next</a>
</div>
<div class="tab-pane active" id="tab_default_1">
<!-- 'text' content area -->
<text><div class="text">
<div class="section">
<span class="chapeau indent0">A <a aria-label="Definitions - drug" class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-3092384-263718883&amp;term_occur=999&amp;term_src=title:21:chapter:9:subchapter:V:part:A:section:351">drug</a> or <a aria-label="Definitions - device" class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-1335157162-263717922&amp;term_occur=999&amp;term_src=title:21:chapter:9:subchapter:V:part:A:section:351">device</a> shall be deemed to be adulterated—</span>
<div class="subsection indent2 firstIndent-2"><a name="a"></a><span class="num bold" value="a">(a)</span><span class="heading bold"> Poisonous, insanitary, etc., ingredients; adequate controls in manufacture</span>
<div class="paragraph indent0"><a name="a_1"></a><span class="num" value="1">(1)</span>
<div class="content"> If it consists in whole or in part of any filthy, putrid, or decomposed substance; or (2)(A) if it has been prepared, packed, or held under insanitary conditions whereby it may have been contaminated with filth, or whereby it may have been rendered injurious to health; or (B) if it is a <a aria-label="Definitions - drug" class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-3092384-263718883&amp;term_occur=999&amp;term_src=title:21:chapter:9:subchapter:V:part:A:section:351">drug</a> and the methods used in, or the facilities or controls used for, its manufacture, processing, packing, or holding do not conform to or are not operated or administered in conformity with <a aria-label="Definitions - current good manufacturing practice" class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-531058297-751022202&amp;term_occur=999&amp;term_src=title:21:chapter:9:subchapter:V:part:A:section:351">current good manufacturing practice</a> to assure that such<a aria-label="Definitions -  drug " class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-3092384-263718883&amp;term_occur=999&amp;term_src="> drug </a>meets the requirements of this chapter as to safety and has the identity and strength, and meets the quality and purity characteristics, which it purports or is represented to possess; or (C) if it is a compounded positron emission tomography<a aria-label="Definitions -  drug " class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-3092384-263718883&amp;term_occur=999&amp;term_src="> drug </a>and the methods used in, or the facilities and controls used for, its compounding, processing, packing, or holding do not conform to or are not operated or administered in conformity with the positron emission tomography compounding standards and the official monographs of the United<a aria-label="Definitions -  States " class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-80204913-263724649&amp;term_occur=999&amp;term_src="> States </a>Pharmacopoeia to assure that such<a aria-label="Definitions -  drug " class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-3092384-263718883&amp;term_occur=999&amp;term_src="> drug </a>meets the requirements of this chapter as to safety and has the identity and strength, and meets the quality and purity characteristics, that it purports or is represented to possess; or (3) if its container is composed, in whole or in part, of any poisonous or deleterious substance which may render the contents injurious to health; or (4) if (A) it bears or contains, for purposes of coloring only, a<a aria-label="Definitions -  color additive " class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-1714025495-415036830&amp;term_occur=999&amp;term_src=title:21:chapter:9:subchapter:V:part:A:section:351"> color additive </a>which is unsafe within the meaning of <a href="/uscode/text/21/379e#a">section 379e(a) of this title</a>, or (B) it is a<a aria-label="Definitions -  color additive " class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-1714025495-415036830&amp;term_occur=999&amp;term_src=title:21:chapter:9:subchapter:V:part:A:section:351"> color additive </a>the intended use of which in or on<a aria-label="Definitions -  drugs " class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-3092384-263718883&amp;term_occur=999&amp;term_src=title:21:chapter:9:subchapter:V:part:A:section:351"> drugs </a>or<a aria-label="Definitions -  devices " class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-1335157162-263717922&amp;term_occur=999&amp;term_src=title:21:chapter:9:subchapter:V:part:A:section:351"> devices </a>is for purposes of coloring only and is unsafe within the meaning of <a href="/uscode/text/21/379e#a">section 379e(a) of this title</a>; or (5) if it is a<a aria-label="Definitions -  new animal drug " class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-1064905532-751111563&amp;term_occur=999&amp;term_src=title:21:chapter:9:subchapter:V:part:A:section:351"> new animal drug </a>which is unsafe within the meaning of <a href="/uscode/text/21/360b">section 360b of this title</a>; or (6) if it is an<a aria-label="Definitions -  animal feed " class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-849519938-751111562&amp;term_occur=999&amp;term_src=title:21:chapter:9:subchapter:V:part:A:section:351"> animal feed </a>bearing or containing a<a aria-label="Definitions -  new animal drug," class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-1064905532-751111563&amp;term_occur=999&amp;term_src=title:21:chapter:9:subchapter:V:part:A:section:351"> new animal drug,</a> and such<a aria-label="Definitions -  animal feed " class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-849519938-751111562&amp;term_occur=999&amp;term_src=title:21:chapter:9:subchapter:V:part:A:section:351"> animal feed </a>is unsafe within the meaning of <a href="/uscode/text/21/360b">section 360b of this title</a>.</div>
</div>
</div>
<div class="subsection indent2 firstIndent-2"><a name="b"></a><span class="num bold" value="b">(b)</span><span class="heading bold"> Strength, quality, or purity differing from official compendium</span>
<div class="content">
<p>If it purports to be or is represented as a <a aria-label="Definitions - drug" class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-3092384-263718883&amp;term_occur=999&amp;term_src=title:21:chapter:9:subchapter:V:part:A:section:351">drug</a> the name of which is recognized in an <a aria-label="Definitions - official compendium" class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-1698311638-751111575&amp;term_occur=999&amp;term_src=title:21:chapter:9:subchapter:V:part:A:section:351">official compendium</a>, and its strength differs from, or its quality or purity falls below, the standard set forth in such compendium. Such determination as to strength, quality, or purity shall be made in accordance with the tests or methods of assay set forth in such compendium, except that whenever tests or methods of assay have not been prescribed in such compendium, or such tests or methods of assay as are prescribed are, in the judgment of the<a aria-label="Definitions -  Secretary," class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-1264422296-751111581&amp;term_occur=999&amp;term_src=title:21:chapter:9:subchapter:V:part:A:section:351"> Secretary,</a> insufficient for the making of such determination, the<a aria-label="Definitions -  Secretary " class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-1264422296-751111581&amp;term_occur=999&amp;term_src="> Secretary </a>shall bring such fact to the attention of the appropriate body charged with the revision of such compendium, and if such body fails within a reasonable time to prescribe tests or methods of assay which, in the judgment of the<a aria-label="Definitions -  Secretary," class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-1264422296-751111581&amp;term_occur=999&amp;term_src=title:21:chapter:9:subchapter:V:part:A:section:351"> Secretary,</a> are sufficient for purposes of this paragraph, then the<a aria-label="Definitions -  Secretary " class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-1264422296-751111581&amp;term_occur=999&amp;term_src="> Secretary </a>shall promulgate regulations prescribing appropriate tests or methods of assay in accordance with which such determination as to strength, quality, or purity shall be made. No<a aria-label="Definitions -  drug " class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-3092384-263718883&amp;term_occur=999&amp;term_src="> drug </a>defined in an <a aria-label="Definitions - official compendium" class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-1698311638-751111575&amp;term_occur=999&amp;term_src=title:21:chapter:9:subchapter:V:part:A:section:351">official compendium</a> shall be deemed to be adulterated under this paragraph because it differs from the standard of strength, quality, or purity therefor set forth in such compendium, if its difference in strength, quality, or purity from such standard is plainly stated on its<a aria-label="Definitions -  label." class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-102727412-751111574&amp;term_occur=999&amp;term_src=title:21:chapter:9:subchapter:V:part:A:section:351"> label.</a> Whenever a<a aria-label="Definitions -  drug " class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-3092384-263718883&amp;term_occur=999&amp;term_src="> drug </a>is recognized in both the United<a aria-label="Definitions -  States " class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-80204913-263724649&amp;term_occur=999&amp;term_src="> States </a>Pharmacopoeia and the Homoeopathic Pharmacopoeia of the United<a aria-label="Definitions -  States " class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-80204913-263724649&amp;term_occur=999&amp;term_src="> States </a>it shall be subject to the requirements of the United<a aria-label="Definitions -  States " class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-80204913-263724649&amp;term_occur=999&amp;term_src="> States </a>Pharmacopoeia unless it is labeled and offered for sale as a homoeopathic<a aria-label="Definitions -  drug," class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-3092384-263718883&amp;term_occur=999&amp;term_src=title:21:chapter:9:subchapter:V:part:A:section:351"> drug,</a> in which case it shall be subject to the provisions of the Homoeopathic Pharmacopoeia of the United<a aria-label="Definitions -  States " class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-80204913-263724649&amp;term_occur=999&amp;term_src="> States </a>and not to those of the United<a aria-label="Definitions -  States " class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-80204913-263724649&amp;term_occur=999&amp;term_src="> States </a>Pharmacopoeia.</p>
</div>
</div>
<div class="subsection indent2 firstIndent-2"><a name="c"></a><span class="num bold" value="c">(c)</span><span class="heading bold"> Misrepresentation of strength, etc., where drug is unrecognized in compendium</span>
<div class="content">
<p>If it is not subject to the provisions of paragraph (b) of this section and its strength differs from, or its purity or quality falls below, that which it purports or is represented to possess.</p>
</div>
</div>
<div class="subsection indent2 firstIndent-2"><a name="d"></a><span class="num bold" value="d">(d)</span><span class="heading bold"> Mixture with or substitution of another substance</span>
<div class="content">
<p>If it is a <a aria-label="Definitions - drug" class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-3092384-263718883&amp;term_occur=999&amp;term_src=title:21:chapter:9:subchapter:V:part:A:section:351">drug</a> and any substance has been (1) mixed or packed therewith so as to reduce its quality or strength or (2) substituted wholly or in part therefor.</p>
</div>
</div>
<div class="subsection indent2 firstIndent-2"><a name="e"></a><span class="num bold" value="e">(e)</span><span class="heading bold"> Devices not in conformity with performance standards</span>
<div class="paragraph indent0"><a name="e_1"></a><span class="num" value="1">(1)</span>
<div class="content"> If it is, or purports to be or is represented as, a <a aria-label="Definitions - device" class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-1335157162-263717922&amp;term_occur=999&amp;term_src=title:21:chapter:9:subchapter:V:part:A:section:351">device</a> which is subject to a performance standard established under <a href="/uscode/text/21/360d">section 360d of this title</a> unless such<a aria-label="Definitions -  device " class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-1335157162-263717922&amp;term_occur=999&amp;term_src="> device </a>is in all respects in conformity with such standard.</div>
</div>
<div class="paragraph indent0"><a name="e_2"></a><span class="num" value="2">(2)</span>
<div class="content"> If it is declared to be, purports to be, or is represented as, a <a aria-label="Definitions - device" class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-1335157162-263717922&amp;term_occur=999&amp;term_src=title:21:chapter:9:subchapter:V:part:A:section:351">device</a> that is in conformity with any standard recognized under <a href="/uscode/text/21/360d#c">section 360d(c) of this title</a> unless such<a aria-label="Definitions -  device " class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-1335157162-263717922&amp;term_occur=999&amp;term_src="> device </a>is in all respects in conformity with such standard.</div>
</div>
</div>
<div class="subsection indent2 firstIndent-2"><a name="f"></a><span class="num bold" value="f">(f)</span><span class="heading bold"> Certain class III devices</span>
<div class="paragraph indent0"><a name="f_1"></a><span class="num" value="1">(1)</span><span class="chapeau"> If it is a class III <a aria-label="Definitions - device" class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-1335157162-263717922&amp;term_occur=999&amp;term_src=title:21:chapter:9:subchapter:V:part:A:section:351">device</a>—</span>
<div class="subparagraph indent1"><a name="f_1_A"></a><span class="num" value="A">(A)</span>
<div class="clause indent1"><a name="f_1_A_i"></a><span class="num" value="i">(i)</span>
<div class="content"> which is required by an order issued under subsection (b) of <a href="/uscode/text/21/360e">section 360e of this title</a> to have an approval under such section of an application for premarket approval and which is not exempt from <a href="/uscode/text/21/360e">section 360e of this title</a> under <a href="/uscode/text/21/360j#g">section 360j(g) of this title</a>, and</div>
</div>
<div class="clause indent1"><a name="f_1_A_ii"></a><span class="num" value="ii">(ii)</span>
<div class="subclause indent1"><a name="f_1_A_ii_I"></a><span class="num" value="I">(I)</span>
<div class="content"> for which an application for premarket approval or a notice of completion of a product development protocol was not filed with the <a aria-label="Definitions - Secretary" class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-1264422296-751111581&amp;term_occur=999&amp;term_src=title:21:chapter:9:subchapter:V:part:A:section:351">Secretary</a> within the ninety-day period beginning on the date of the issuance of such order, or</div>
</div>
<div class="subclause indent1"><a name="f_1_A_ii_II"></a><span class="num" value="II">(II)</span>
<div class="content"> for which such an application was filed and approval of the application has been denied, suspended, or withdrawn, or such a notice was filed and has been declared not completed or the approval of the <a aria-label="Definitions - device" class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-1335157162-263717922&amp;term_occur=999&amp;term_src=title:21:chapter:9:subchapter:V:part:A:section:351">device</a> under the protocol has been withdrawn;</div>
</div>
</div>
</div>
<div class="subparagraph indent1"><a name="f_1_B"></a><span class="num" value="B">(B)</span>
<div class="clause indent1"><a name="f_1_B_i"></a><span class="num" value="i">(i)</span>
<div class="content"> which was classified under <a href="/uscode/text/21/360c#f">section 360c(f) of this title</a> into class III, which under <a href="/uscode/text/21/360e#a">section 360e(a) of this title</a> is required to have in effect an approved application for premarket approval, and which is not exempt from <a href="/uscode/text/21/360e">section 360e of this title</a> under <a href="/uscode/text/21/360j#g">section 360j(g) of this title</a>, and</div>
</div>
<div class="clause indent1"><a name="f_1_B_ii"></a><span class="num" value="ii">(ii)</span>
<div class="content"> which has an application which has been suspended or is otherwise not in effect; or</div>
</div>
</div>
<div class="subparagraph indent1"><a name="f_1_C"></a><span class="num" value="C">(C)</span>
<div class="content" stripi="True"> which was classified under <a aria-label="21 USC 360j l" href="/uscode/text/21/360j#l">section 360j(l) of this title</a> into class III, which under such section is required to have in effect an approved application under <a href="/uscode/text/21/360e">section 360e of this title</a>, and which has an application which has been suspended or is otherwise not in effect.</div>
</div>
</div>
<div class="paragraph indent0"><a name="f_2"></a><span class="num" value="2">(2)</span>
<div class="subparagraph indent0"><a name="f_2_A"></a><span class="num" value="A">(A)</span>
<div class="content"> In the case of a <a aria-label="Definitions - device" class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-1335157162-263717922&amp;term_occur=999&amp;term_src=title:21:chapter:9:subchapter:V:part:A:section:351">device</a> classified under <a href="/uscode/text/21/360c#f">section 360c(f) of this title</a> into class III and intended solely for investigational use, paragraph <a class="footnoteRef" href="#fn002030" id="fn002030-ref" name="fn002030-ref">[1]</a> (1)(B) shall not apply with respect to such<a aria-label="Definitions -  device " class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-1335157162-263717922&amp;term_occur=999&amp;term_src="> device </a>during the period ending on the ninetieth day after the date of the promulgation of the regulations prescribing the procedures and conditions required by <a href="/uscode/text/21/360j#g_2">section 360j(g)(2) of this title</a>.</div>
</div>
<div class="subparagraph indent0"><a name="f_2_B"></a><span class="num" value="B">(B)</span><span class="chapeau"> In the case of a <a aria-label="Definitions - device" class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-1335157162-263717922&amp;term_occur=999&amp;term_src=title:21:chapter:9:subchapter:V:part:A:section:351">device</a> subject to an order issued under subsection (b) of <a href="/uscode/text/21/360e">section 360e of this title</a>, paragraph <sup>1</sup> (1) shall not apply with respect to such<a aria-label="Definitions -  device " class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-1335157162-263717922&amp;term_occur=999&amp;term_src="> device </a>during the period ending—</span>
<div class="clause indent1"><a name="f_2_B_i"></a><span class="num" value="i">(i)</span>
<div class="content"> on the last day of the thirtieth calendar month beginning after the month in which the classification of the <a aria-label="Definitions - device" class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-1335157162-263717922&amp;term_occur=999&amp;term_src=title:21:chapter:9:subchapter:V:part:A:section:351">device</a> in class III became effective under <a href="/uscode/text/21/360c">section 360c of this title</a>, or</div>
</div>
<div class="clause indent1"><a name="f_2_B_ii"></a><span class="num" value="ii">(ii)</span>
<div class="content"> on the ninetieth day after the date of the issuance of such order,</div>
</div>
<div class="continuation indent0 firstIndent0">whichever occurs later.</div>
</div>
</div>
<div class="paragraph indent0"><a name="f_3"></a><span class="num" value="3">(3)</span>
<div class="content"> In the case of a <a aria-label="Definitions - device" class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-1335157162-263717922&amp;term_occur=999&amp;term_src=title:21:chapter:9:subchapter:V:part:A:section:351">device</a> with respect to which a regulation was promulgated under <a href="/uscode/text/21/360e#b">section 360e(b) of this title</a> prior to <span class="date" date="2012-07-09">July 9, 2012</span>, a reference in this subsection to an order issued under <a href="/uscode/text/21/360e#b">section 360e(b) of this title</a> shall be deemed to include such regulation.</div>
</div>
</div>
<div class="subsection indent2 firstIndent-2"><a name="g"></a><span class="num bold" value="g">(g)</span><span class="heading bold"> Banned devices</span>
<div class="content">
<p>If it is a banned <a aria-label="Definitions - device" class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-1335157162-263717922&amp;term_occur=999&amp;term_src=title:21:chapter:9:subchapter:V:part:A:section:351">device</a>.</p>
</div>
</div>
<div class="subsection indent2 firstIndent-2"><a name="h"></a><span class="num bold" value="h">(h)</span><span class="heading bold"> Manufacture, packing, storage, or installation of device not in conformity with applicable requirements or conditions</span>
<div class="content">
<p>If it is a <a aria-label="Definitions - device" class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-1335157162-263717922&amp;term_occur=999&amp;term_src=title:21:chapter:9:subchapter:V:part:A:section:351">device</a> and the methods used in, or the facilities or controls used for, its manufacture, packing, storage, or installation are not in conformity with applicable requirements under <a href="/uscode/text/21/360j#f_1">section 360j(f)(1) of this title</a> or an applicable condition prescribed by an order under <a href="/uscode/text/21/360j#f_2">section 360j(f)(2) of this title</a>.</p>
</div>
</div>
<div class="subsection indent2 firstIndent-2"><a name="i"></a><span class="num bold" value="i">(i)</span><span class="heading bold"> Failure to comply with requirements under which device was exempted for investigational use</span>
<div class="content">
<p>If it is a <a aria-label="Definitions - device" class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-1335157162-263717922&amp;term_occur=999&amp;term_src=title:21:chapter:9:subchapter:V:part:A:section:351">device</a> for which an exemption has been granted under <a href="/uscode/text/21/360j#g">section 360j(g) of this title</a> for investigational use and the<a aria-label="Definitions -  person " class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-991716523-751111580&amp;term_occur=999&amp;term_src=title:21:chapter:9:subchapter:V:part:A:section:351"> person </a>who was granted such exemption or any investigator who uses such<a aria-label="Definitions -  device " class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-1335157162-263717922&amp;term_occur=999&amp;term_src="> device </a>under such exemption fails to comply with a requirement prescribed by or under such section.</p>
</div>
</div>
<div class="subsection indent2 firstIndent-2"><a name="j"></a><span class="num bold" value="j">(j)</span><span class="heading bold"> Delayed, denied, or limited inspection; refusal to permit entry or inspection</span>
<div class="content">
<p>If it is a <a aria-label="Definitions - drug" class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-3092384-263718883&amp;term_occur=999&amp;term_src=title:21:chapter:9:subchapter:V:part:A:section:351">drug</a> or <a aria-label="Definitions - device" class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-1335157162-263717922&amp;term_occur=999&amp;term_src=title:21:chapter:9:subchapter:V:part:A:section:351">device</a> and it has been manufactured, processed, packed, or held in any factory, warehouse, or establishment and the owner, operator, or agent of such factory, warehouse, or establishment delays, denies, or limits an inspection, or refuses to permit entry or inspection.</p>
<p>For purposes of paragraph (a)(2)(B), the term “<a aria-label="Definitions - current good manufacturing practice" class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-531058297-751022202&amp;term_occur=999&amp;term_src=title:21:chapter:9:subchapter:V:part:A:section:351">current good manufacturing practice</a>” includes the implementation of oversight and controls over the manufacture of<a aria-label="Definitions -  drugs " class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-3092384-263718883&amp;term_occur=999&amp;term_src=title:21:chapter:9:subchapter:V:part:A:section:351"> drugs </a>to ensure quality, including managing the risk of and establishing the safety of raw materials, materials used in the manufacturing of<a aria-label="Definitions -  drugs," class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-3092384-263718883&amp;term_occur=999&amp;term_src=title:21:chapter:9:subchapter:V:part:A:section:351"> drugs,</a> and finished<a aria-label="Definitions -  drug products." class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-2046232465-1809622431&amp;term_occur=999&amp;term_src=title:21:chapter:9:subchapter:V:part:A:section:351"> drug products.</a></p>
</div>
</div>
<div class="sourceCredit">(June 25, 1938, ch. 675, § 501, <a href="/rio/citation/52_Stat._1049">52 Stat. 1049</a>; <a href="/rio/citation/Pub._L._86-618">Pub. L. 86–618, title I, § 102(b)(1)</a>, <span class="date" date="1960-07-12">July 12, 1960</span>, <a href="/rio/citation/74_Stat._398">74 Stat. 398</a>; <a href="/rio/citation/Pub._L._87-781">Pub. L. 87–781, title I, § 101</a>, <span class="date" date="1962-10-10">Oct. 10, 1962</span>, <a href="/rio/citation/76_Stat._780">76 Stat. 780</a>; <a href="/rio/citation/Pub._L._90-399">Pub. L. 90–399, § 101(a)</a>, <span class="date" date="1968-07-13">July 13, 1968</span>, <a href="/rio/citation/82_Stat._343">82 Stat. 343</a>; <a href="/rio/citation/Pub._L._94-295">Pub. L. 94–295</a>, §§ 3(d), 9(b)(1), <span class="date" date="1976-05-28">May 28, 1976</span>, <a href="/rio/citation/90_Stat._576">90 Stat. 576</a>, 583; <a href="/rio/citation/Pub._L._101-629">Pub. L. 101–629, § 9(b)</a>, <span class="date" date="1990-11-28">Nov. 28, 1990</span>, <a href="/rio/citation/104_Stat._4521">104 Stat. 4521</a>; <a href="/rio/citation/Pub._L._102-571">Pub. L. 102–571, title I, § 107(8)</a>, <span class="date" date="1992-10-29">Oct. 29, 1992</span>, <a href="/rio/citation/106_Stat._4499">106 Stat. 4499</a>; <a href="/rio/citation/Pub._L._105-115">Pub. L. 105–115, title I, § 121(b)(1)</a>, title II, § 204(c), <span class="date" date="1997-11-21">Nov. 21, 1997</span>, <a href="/rio/citation/111_Stat._2320">111 Stat. 2320</a>, 2336; <a href="/rio/citation/Pub._L._112-144">Pub. L. 112–144, title VI, § 608(b)(2)</a>, title VII, §§ 707(a), 711, <span class="date" date="2012-07-09">July 9, 2012</span>, <a href="/rio/citation/126_Stat._1058">126 Stat. 1058</a>, 1068, 1071; <a href="/rio/citation/Pub._L._115-52">Pub. L. 115–52, title VII, § 702(c)</a>, <span class="date" date="2017-08-18">Aug. 18, 2017</span>, <a href="/rio/citation/131_Stat._1056">131 Stat. 1056</a>.)</div>
</div>
</div></text>
</div>
<div class="tab-pane" id="tab_default_2">
<!-- 'notes' content area -->
<notes><div class="notes">
<hr class="footsep"/><br/><a class="footnote" href="#fn002030-ref" id="fn002030" name="fn002030">[1] </a><span class="footnote"> So in original. Probably should be “subparagraph”.</span><br/></div><div class="notes">
<div class="note" topic="editorialNotes"><span class="heading centered"><strong>Editorial Notes</strong></span></div>
<div class="note" topic="amendments"><span class="heading centered smallCaps">Amendments</span>
<p>2017—Par. (j). <a href="/rio/citation/Pub._L._115-52">Pub. L. 115–52</a> inserted “or<a aria-label="Definitions -  device”" class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-1335157162-263717922&amp;term_occur=999&amp;term_src="> device”</a> after <a aria-label="Definitions - “drug”" class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-3092384-263718883&amp;term_occur=999&amp;term_src=">“drug”</a>.</p>
<p>2012—<a href="/rio/citation/Pub._L._112-144">Pub. L. 112–144, § 711</a>, inserted concluding provisions.</p>
<p>Par. (f)(1)(A)(i). <a href="/rio/citation/Pub._L._112-144">Pub. L. 112–144, § 608(b)(2)(A)(i)</a>, substituted “an order issued” for “a regulation promulgated”.</p>
<p>Par. (f)(1)(A)(ii)(I). <a href="/rio/citation/Pub._L._112-144">Pub. L. 112–144, § 608(b)(2)(A)(ii)</a>, substituted “issuance of such order” for “promulgation of such regulation”.</p>
<p>Par. (f)(2)(B). <a href="/rio/citation/Pub._L._112-144">Pub. L. 112–144, § 608(b)(2)(B)</a>, substituted “an order issued” for “a regulation promulgated” in introductory provisions and “issuance of such order” for “promulgation of such regulation” in subcl. (ii).</p>
<p>Par. (f)(3). <a href="/rio/citation/Pub._L._112-144">Pub. L. 112–144, § 608(b)(2)(C)</a>, added subpar. (3).</p>
<p>Par. (j). <a href="/rio/citation/Pub._L._112-144">Pub. L. 112–144, § 707(a)</a>, added par. (j).</p>
<p>1997—Par. (a)(2)(C). <a href="/rio/citation/Pub._L._105-115">Pub. L. 105–115, § 121(b)(1)</a>, inserted “; or (C) if it is a compounded positron emission tomography<a aria-label="Definitions -  drug " class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-3092384-263718883&amp;term_occur=999&amp;term_src="> drug </a>and the methods used in, or the facilities and controls used for, its compounding, processing, packing, or holding do not conform to or are not operated or administered in conformity with the positron emission tomography compounding standards and the official monographs of the United<a aria-label="Definitions -  States " class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-80204913-263724649&amp;term_occur=999&amp;term_src="> States </a>Pharmacopoeia to assure that such<a aria-label="Definitions -  drug " class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-3092384-263718883&amp;term_occur=999&amp;term_src="> drug </a>meets the requirements of this chapter as to safety and has the identity and strength, and meets the quality and purity characteristics, that it purports or is represented to possess;” before “or (3)”.</p>
<p>Par. (e). <a href="/rio/citation/Pub._L._105-115">Pub. L. 105–115, § 204(c)</a>, designated existing provisions as subpar. (1) and added subpar. (2).</p>
<p>1992—Par. (a)(4). <a href="/rio/citation/Pub._L._102-571">Pub. L. 102–571</a> substituted “379e(a)” for “376(a)” in cls. (A) and (B).</p>
<p>1990—Par. (f)(1). <a href="/rio/citation/Pub._L._101-629">Pub. L. 101–629, § 9(b)</a>, which directed the amendment of subpars. (A) to (C) of par. (f), was executed by making the amendments in cls. (A) to (C) of subpar. (1) of par. (f) as follows to reflect the probable intent of <span link="https://liicornell.org/liifedent/congress" occur="1" src="named_federal_agencies">Congress</span>: in cl. (A)(ii)(II), substituted “, suspended, or withdrawn” for “or withdrawn”; in cl. (B)(ii), substituted “which has an application which has been suspended or is otherwise not in effect” for “which does not have such an application in effect”; and in cl. (C), substituted “which has an application which has been suspended or is otherwise not in effect” for “which does not have such an application in effect”.</p>
<p>1976—Par. (a). <a href="/rio/citation/Pub._L._94-295">Pub. L. 94–295, § 9(b)(1)</a>, substituted “(3) if its” for “(3) if it is a<a aria-label="Definitions -  drug " class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-3092384-263718883&amp;term_occur=999&amp;term_src="> drug </a>and its” in cl. (3), substituted “(4) if (A) it bears or contains” for “(4) if (A) it is a<a aria-label="Definitions -  drug " class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-3092384-263718883&amp;term_occur=999&amp;term_src="> drug </a>which bears or contains” in cl. (4)(A), and substituted <a aria-label="Definitions - “drugs " class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-3092384-263718883&amp;term_occur=999&amp;term_src=">“drugs </a>or<a aria-label="Definitions -  devices”" class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-1335157162-263717922&amp;term_occur=999&amp;term_src="> devices”</a> for <a aria-label="Definitions - “drugs”" class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-3092384-263718883&amp;term_occur=999&amp;term_src=">“drugs”</a> in cl. (4)(B).</p>
<p>Pars. (e) to (i). <a href="/rio/citation/Pub._L._94-295">Pub. L. 94–295, § 3(d)</a>, added pars. (e) to (i).</p>
<p>1968—Par. (a). <a href="/rio/citation/Pub._L._90-399">Pub. L. 90–399</a> added cls. (5) and (6).</p>
<p>1962—Par. (a). <a href="/rio/citation/Pub._L._87-781">Pub. L. 87–781</a> designated existing provisions of cl. (2) as (A) and added (B).</p>
<p>1960—Par. (a). <a href="/rio/citation/Pub._L._86-618">Pub. L. 86–618</a> substituted provisions in cl. (4) relating to unsafe<a aria-label="Definitions -  color additives " class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-1714025495-415036830&amp;term_occur=999&amp;term_src="> color additives </a>for provisions which related to a coal-tar<a aria-label="Definitions -  color " class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-94842723-415036831&amp;term_occur=999&amp;term_src="> color </a>other than one from a batch that has been certified in accordance with regulations as provided by <a href="/uscode/text/21/354">section 354 of this title</a>.</p>
</div>
<div class="note" topic="statutoryNotes"><span class="heading centered"><strong>Statutory Notes and Related Subsidiaries</strong></span></div>
<div class="note" topic="effectiveDateOfAmendment"><span class="heading centered smallCaps">Effective and Termination Dates of 1997 Amendment</span>
<p><a href="/rio/citation/Pub._L._105-115">Pub. L. 105–115, title I, § 121(b)(2)</a>, <span class="date" date="1997-11-21">Nov. 21, 1997</span>, <a href="/rio/citation/111_Stat._2320">111 Stat. 2320</a>, provided that: </p><div class="quotedContent" origin="/us/pl/105/115/tI/s121/b/2">“Section 501(a)(2)(C) of the <a href="/topn/federal_food_drug_and_cosmetic_act">Federal Food, Drug, and Cosmetic Act</a> (<a href="https://www.law.cornell.edu/uscode/text/21/351#a_2_C">21 U.S.C. 351(a)(2)(C)</a>) shall not apply 4 years after the date of enactment of this Act [<span class="date" date="1997-11-21">Nov. 21, 1997</span>] or 2 years after the date on which the<a aria-label="Definitions -  Secretary " class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-1264422296-751111581&amp;term_occur=999&amp;term_src="> Secretary </a>of Health and Human Services establishes the requirements described in subsection (c)(1)(B) [<a href="/rio/citation/Pub._L._105-115">section 121(c)(1)(B) of Pub. L. 105–115</a>, set out as a note under <a href="/uscode/text/21/355">section 355 of this title</a>], whichever is later.”</div>
<p>Amendment by <a href="/rio/citation/Pub._L._105-115">Pub. L. 105–115</a> effective 90 days after <span class="date" date="1997-11-21">Nov. 21, 1997</span>, except as otherwise provided, see <a href="/rio/citation/Pub._L._105-115">section 501 of Pub. L. 105–115</a>, set out as an Effective Date of 1997 Amendment note under <a href="/uscode/text/21/321">section 321 of this title</a>.</p>
</div>
<div class="note" topic="effectiveDateOfAmendment"><span class="heading centered smallCaps">Effective Date of 1968 Amendment</span>
<p>Amendment by <a href="/rio/citation/Pub._L._90-399">Pub. L. 90–399</a> effective on first day of thirteenth calendar month after <span class="date" date="1968-07-13">July 13, 1968</span>, see <a href="/rio/citation/Pub._L._90-399">section 108(a) of Pub. L. 90–399</a>, set out as an Effective Date and Transitional Provisions note under <a href="/uscode/text/21/360b">section 360b of this title</a>.</p>
</div>
<div class="note" topic="effectiveDateOfAmendment"><span class="heading centered smallCaps">Effective Date of 1962 Amendment; Exceptions</span>
<p>Amendment by <a href="/rio/citation/Pub._L._87-781">Pub. L. 87–781</a> effective on first day of seventh calendar month following October 1962, see <a href="/rio/citation/Pub._L._87-781">section 107 of Pub. L. 87–781</a>, set out as a note under <a href="/uscode/text/21/321">section 321 of this title</a>.</p>
</div>
<div class="note" topic="effectiveDateOfAmendment"><span class="heading centered smallCaps">Effective Date of 1960 Amendment</span>
<p>Amendment by <a href="/rio/citation/Pub._L._86-618">Pub. L. 86–618</a> effective <span class="date" date="1960-07-12">July 12, 1960</span>, subject to the provisions of <a href="/rio/citation/Pub._L._86-618">section 203 of Pub. L. 86–618</a>, see <a href="/rio/citation/Pub._L._86-618">section 202 of Pub. L. 86–618</a>, set out as a note under <a href="/uscode/text/21/379e">section 379e of this title</a>.</p>
</div>
<div class="note" topic="effectiveDate"><span class="heading centered smallCaps">Effective Date; Postponement</span>
<p>Par. (a)(4) effective <span class="date" date="1940-01-01">Jan. 1, 1940</span>, see act June 23, 1939, ch. 242, <a href="/rio/citation/53_Stat._853">53 Stat. 853</a>, set out as an Effective Date; Postponement in Certain Cases note under <a href="/uscode/text/21/301">section 301 of this title</a>.</p>
</div>
<div class="note" topic="miscellaneous"><span class="heading centered smallCaps">Approval by Regulation Prior to <span class="date" date="2012-07-09">July 9, 2012</span></span>
<p><a href="/rio/citation/Pub._L._112-144">Pub. L. 112–144, title VI, § 608(b)(3)</a>, <span class="date" date="2012-07-09">July 9, 2012</span>, <a href="/rio/citation/126_Stat._1059">126 Stat. 1059</a>, provided that: </p><div class="quotedContent" origin="/us/pl/112/144/tVI/s608/b/3">“The amendments made by this subsection [amending this section and <a href="/uscode/text/21/360e">section 360e of this title</a>] shall have no effect on a regulation that was promulgated prior to the date of enactment of this Act [<span class="date" date="2012-07-09">July 9, 2012</span>] requiring that a<a aria-label="Definitions -  device " class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-1335157162-263717922&amp;term_occur=999&amp;term_src="> device </a>have an approval under section 515 of the <a href="/topn/federal_food_drug_and_cosmetic_act">Federal Food, Drug, and Cosmetic Act</a> (<a href="https://www.law.cornell.edu/uscode/text/21/360e">21 U.S.C. 360e</a>) of an application for premarket approval.”</div>
</div>
<div class="note" topic="miscellaneous"><span class="heading centered smallCaps">Guidance</span>
<p><a href="/rio/citation/Pub._L._112-144">Pub. L. 112–144, title VII, § 707(b)</a>, <span class="date" date="2012-07-09">July 9, 2012</span>, <a href="/rio/citation/126_Stat._1068">126 Stat. 1068</a>, provided that: </p><div class="quotedContent" origin="/us/pl/112/144/tVII/s707/b">“Not later than 1 year after the date of enactment of this section [<span class="date" date="2012-07-09">July 9, 2012</span>], the<a aria-label="Definitions -  Secretary " class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-1264422296-751111581&amp;term_occur=999&amp;term_src="> Secretary </a>of Health and Human Services shall issue guidance that defines the circumstances that would constitute delaying, denying, or limiting inspection, or refusing to permit entry or inspection, for purposes of section 501(j) of the <a href="/topn/federal_food_drug_and_cosmetic_act">Federal Food, Drug, and Cosmetic Act</a> [<a href="https://www.law.cornell.edu/uscode/text/21/351#j">21 U.S.C. 351(j)</a>] (as added by subsection (a)).”</div>
</div>
<div class="note" topic="execDoc"><span class="heading centered"><strong>Executive Documents</strong></span></div>
<div class="note" topic="transferOfFunctions">
<span class="heading centered smallCaps">Transfer of Functions</span>
<p>For transfer of functions of Federal Security <a aria-label="Definitions - Administrator" class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-146731693-1809622303&amp;term_occur=999&amp;term_src=">Administrator</a> to<a aria-label="Definitions -  Secretary " class="colorbox-load definedterm" href="/definitions/uscode.php?width=840&amp;height=800&amp;iframe=true&amp;def_id=21-USC-1264422296-751111581&amp;term_occur=999&amp;term_src="> Secretary </a>of Health, Education, and Welfare [now Health and Human Services], and of <span link="https://liicornell.org/liifedent/hhs_food_and_drug_administration" occur="1" src="named_federal_agencies">Food and Drug Administration</span> in the <span link="https://liicornell.org/liifedent/department_of_agriculture" occur="1" src="named_federal_agencies">Department of Agriculture</span> to Federal Security Agency, see notes set out under <a href="/uscode/text/21/321">section 321 of this title</a>.</p>
</div>
</div></notes>
</div>
<div class="tab-pane" id="tab_default_3">
<table class="table table-striped">
<thead>
<tr>
<th scope="col">CFR Title</th>
<th scope="col">Parts</th>
</tr>
</thead>
<tbody>
<tr>
<td>21</td>
<td>
<a href="/cfr/text/21/part-2" title="PART 2—GENERAL ADMINISTRATIVE RULINGS AND DECISIONS">
                                                2
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-3" title="PART 3—PRODUCT JURISDICTION">
                                                3
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-4" title="PART 4—REGULATION OF COMBINATION PRODUCTS">
                                                4
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-5" title="PART 5—ORGANIZATION">
                                                5
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-7" title="PART 7—ENFORCEMENT POLICY">
                                                7
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-10" title="PART 10—ADMINISTRATIVE PRACTICES AND PROCEDURES">
                                                10
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-11" title="PART 11—ELECTRONIC RECORDS; ELECTRONIC SIGNATURES">
                                                11
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-12" title="PART 12—FORMAL EVIDENTIARY PUBLIC HEARING">
                                                12
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-13" title="PART 13—PUBLIC HEARING BEFORE A PUBLIC BOARD OF INQUIRY">
                                                13
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-14" title="PART 14—PUBLIC HEARING BEFORE A PUBLIC ADVISORY COMMITTEE">
                                                14
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-15" title="PART 15—PUBLIC HEARING BEFORE THE COMMISSIONER">
                                                15
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-16" title="PART 16—REGULATORY HEARING BEFORE THE FOOD AND DRUG ADMINISTRATION">
                                                16
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-17" title="PART 17—CIVIL MONEY PENALTIES HEARINGS">
                                                17
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-20" title="PART 20—PUBLIC INFORMATION">
                                                20
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-25" title="PART 25—ENVIRONMENTAL IMPACT CONSIDERATIONS">
                                                25
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-26" title="PART 26—MUTUAL RECOGNITION OF PHARMACEUTICAL GOOD MANUFACTURING PRACTICE REPORTS, MEDICAL DEVICE QUALITY SYSTEM AUDIT REPORTS, AND CERTAIN MEDICAL DEVICE PRODUCT EVALUATION REPORTS: UNITED STATES AND THE EUROPEAN COMMUNITY">
                                                26
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-54" title="PART 54—FINANCIAL DISCLOSURE BY CLINICAL INVESTIGATORS">
                                                54
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-56" title="PART 56—INSTITUTIONAL REVIEW BOARDS">
                                                56
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-58" title="PART 58—GOOD LABORATORY PRACTICE FOR NONCLINICAL LABORATORY STUDIES">
                                                58
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-70" title="PART 70—COLOR ADDITIVES">
                                                70
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-71" title="PART 71—COLOR ADDITIVE PETITIONS">
                                                71
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-73" title="PART 73—LISTING OF COLOR ADDITIVES EXEMPT FROM CERTIFICATION">
                                                73
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-74" title="PART 74—LISTING OF COLOR ADDITIVES SUBJECT TO CERTIFICATION">
                                                74
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-99" title="PART 99—DISSEMINATION OF INFORMATION ON UNAPPROVED/NEW USES FOR MARKETED DRUGS, BIOLOGICS, AND DEVICES">
                                                99
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-200" title="PART 200—GENERAL">
                                                200
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-201" title="PART 201—LABELING">
                                                201
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-203" title="PART 203—PRESCRIPTION DRUG MARKETING">
                                                203
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-205" title="PART 205—GUIDELINES FOR STATE LICENSING OF WHOLESALE PRESCRIPTION DRUG DISTRIBUTORS">
                                                205
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-206" title="PART 206—IMPRINTING OF SOLID ORAL DOSAGE FORM DRUG PRODUCTS FOR HUMAN USE">
                                                206
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-207" title="PART 207—REQUIREMENTS FOR FOREIGN AND DOMESTIC ESTABLISHMENT REGISTRATION AND LISTING FOR HUMAN DRUGS, INCLUDING DRUGS THAT ARE REGULATED UNDER A BIOLOGICS LICENSE APPLICATION, AND ANIMAL DRUGS, AND THE NATIONAL DRUG CODE">
                                                207
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-208" title="PART 208—MEDICATION GUIDES FOR PRESCRIPTION DRUG PRODUCTS">
                                                208
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-209" title="PART 209—REQUIREMENT FOR AUTHORIZED DISPENSERS AND PHARMACIES TO DISTRIBUTE A SIDE EFFECTS STATEMENT">
                                                209
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-210" title="PART 210—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PROCESSING, PACKING, OR HOLDING OF DRUGS; GENERAL">
                                                210
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-211" title="PART 211—CURRENT GOOD MANUFACTURING PRACTICE FOR FINISHED PHARMACEUTICALS">
                                                211
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-212" title="PART 212—CURRENT GOOD MANUFACTURING PRACTICE FOR POSITRON EMISSION TOMOGRAPHY DRUGS">
                                                212
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-216" title="PART 216—HUMAN DRUG COMPOUNDING">
                                                216
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-225" title="PART 225—CURRENT GOOD MANUFACTURING PRACTICE FOR MEDICATED FEEDS">
                                                225
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-226" title="PART 226—CURRENT GOOD MANUFACTURING PRACTICE FOR TYPE A MEDICATED ARTICLES">
                                                226
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-299" title="PART 299—DRUGS; OFFICIAL NAMES AND ESTABLISHED NAMES">
                                                299
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-300" title="PART 300—GENERAL">
                                                300
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-310" title="PART 310—NEW DRUGS">
                                                310
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-312" title="PART 312—INVESTIGATIONAL NEW DRUG APPLICATION">
                                                312
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-314" title="PART 314—APPLICATIONS FOR FDA APPROVAL TO MARKET A NEW DRUG">
                                                314
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-315" title="PART 315—DIAGNOSTIC RADIOPHARMACEUTICALS">
                                                315
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-320" title="PART 320—BIOAVAILABILITY AND BIOEQUIVALENCE REQUIREMENTS">
                                                320
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-328" title="PART 328—OVER-THE-COUNTER DRUG PRODUCTS INTENDED FOR ORAL INGESTION THAT CONTAIN ALCOHOL">
                                                328
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-329" title="PART 329—NONPRESCRIPTION HUMAN DRUG PRODUCTS SUBJECT TO SECTION 760 OF THE FEDERAL FOOD, DRUG, AND COSMETIC ACT">
                                                329
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-330" title="PART 330—OVER-THE-COUNTER (OTC) HUMAN DRUGS WHICH ARE GENERALLY RECOGNIZED AS SAFE AND EFFECTIVE AND NOT MISBRANDED">
                                                330
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-331" title="PART 331—ANTACID PRODUCTS FOR OVER-THE-COUNTER (OTC) HUMAN USE">
                                                331
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-332" title="PART 332—ANTIFLATULENT PRODUCTS FOR OVER-THE-COUNTER HUMAN USE">
                                                332
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-333" title="PART 333—TOPICAL ANTIMICROBIAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE">
                                                333
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-335" title="PART 335—ANTIDIARRHEAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE">
                                                335
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-336" title="PART 336—ANTIEMETIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE">
                                                336
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-338" title="PART 338—NIGHTTIME SLEEP-AID DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE">
                                                338
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-340" title="PART 340—STIMULANT DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE">
                                                340
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-341" title="PART 341—COLD, COUGH, ALLERGY, BRONCHODILATOR, AND ANTIASTHMATIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE">
                                                341
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-343" title="PART 343—INTERNAL ANALGESIC, ANTIPYRETIC, AND ANTIRHEUMATIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE">
                                                343
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-344" title="PART 344—TOPICAL OTIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE">
                                                344
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-346" title="PART 346—ANORECTAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE">
                                                346
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-347" title="PART 347—SKIN PROTECTANT DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE">
                                                347
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-348" title="PART 348—EXTERNAL ANALGESIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE">
                                                348
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-349" title="PART 349—OPHTHALMIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE">
                                                349
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-350" title="PART 350—ANTIPERSPIRANT DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE">
                                                350
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-352" title="PART 352—SUNSCREEN DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE [STAYED INDEFINITELY]">
                                                352
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-355" title="PART 355—ANTICARIES DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE">
                                                355
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-357" title="PART 357—MISCELLANEOUS INTERNAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE">
                                                357
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-358" title="PART 358—MISCELLANEOUS EXTERNAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE">
                                                358
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-361" title="PART 361—PRESCRIPTION DRUGS FOR HUMAN USE GENERALLY RECOGNIZED AS SAFE AND EFFECTIVE AND NOT MISBRANDED: DRUGS USED IN RESEARCH">
                                                361
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-369" title="PART 369—INTERPRETATIVE STATEMENTS RE WARNINGS ON DRUGS AND DEVICES FOR OVER-THE-COUNTER SALE">
                                                369
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-500" title="PART 500—GENERAL">
                                                500
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-511" title="PART 511—NEW ANIMAL DRUGS FOR INVESTIGATIONAL USE">
                                                511
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-514" title="PART 514—NEW ANIMAL DRUG APPLICATIONS">
                                                514
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-530" title="PART 530—EXTRALABEL DRUG USE IN ANIMALS">
                                                530
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-570" title="PART 570—FOOD ADDITIVES">
                                                570
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-571" title="PART 571—FOOD ADDITIVE PETITIONS">
                                                571
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-600" title="PART 600—BIOLOGICAL PRODUCTS: GENERAL">
                                                600
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-601" title="PART 601—LICENSING">
                                                601
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-606" title="PART 606—CURRENT GOOD MANUFACTURING PRACTICE FOR BLOOD AND BLOOD COMPONENTS">
                                                606
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-607" title="PART 607—ESTABLISHMENT REGISTRATION AND PRODUCT LISTING FOR MANUFACTURERS OF HUMAN BLOOD AND BLOOD PRODUCTS AND LICENSED DEVICES">
                                                607
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-610" title="PART 610—GENERAL BIOLOGICAL PRODUCTS STANDARDS">
                                                610
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-616" title="">
                                                616
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-630" title="PART 630—REQUIREMENTS FOR BLOOD AND BLOOD COMPONENTS INTENDED FOR TRANSFUSION OR FOR FURTHER MANUFACTURING USE">
                                                630
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-640" title="PART 640—ADDITIONAL STANDARDS FOR HUMAN BLOOD AND BLOOD PRODUCTS">
                                                640
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-660" title="PART 660—ADDITIONAL STANDARDS FOR DIAGNOSTIC SUBSTANCES FOR LABORATORY TESTS">
                                                660
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-680" title="PART 680—ADDITIONAL STANDARDS FOR MISCELLANEOUS PRODUCTS">
                                                680
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-700" title="PART 700—GENERAL">
                                                700
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-800" title="PART 800—GENERAL">
                                                800
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-801" title="PART 801—LABELING">
                                                801
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-807" title="PART 807—ESTABLISHMENT REGISTRATION AND DEVICE LISTING FOR MANUFACTURERS AND INITIAL IMPORTERS OF DEVICES">
                                                807
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-809" title="PART 809—IN VITRO DIAGNOSTIC PRODUCTS FOR HUMAN USE">
                                                809
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-810" title="PART 810—MEDICAL DEVICE RECALL AUTHORITY">
                                                810
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-812" title="PART 812—INVESTIGATIONAL DEVICE EXEMPTIONS">
                                                812
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-814" title="PART 814—PREMARKET APPROVAL OF MEDICAL DEVICES">
                                                814
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-820" title="PART 820—QUALITY SYSTEM REGULATION">
                                                820
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-821" title="PART 821—MEDICAL DEVICE TRACKING REQUIREMENTS">
                                                821
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-861" title="PART 861—PROCEDURES FOR PERFORMANCE STANDARDS DEVELOPMENT">
                                                861
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-862" title="PART 862—CLINICAL CHEMISTRY AND CLINICAL TOXICOLOGY DEVICES">
                                                862
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-864" title="PART 864—HEMATOLOGY AND PATHOLOGY DEVICES">
                                                864
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-866" title="PART 866—IMMUNOLOGY AND MICROBIOLOGY DEVICES">
                                                866
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-868" title="PART 868—ANESTHESIOLOGY DEVICES">
                                                868
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-870" title="PART 870—CARDIOVASCULAR DEVICES">
                                                870
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-872" title="PART 872—DENTAL DEVICES">
                                                872
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-874" title="PART 874—EAR, NOSE, AND THROAT DEVICES">
                                                874
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-876" title="PART 876—GASTROENTEROLOGY-UROLOGY DEVICES">
                                                876
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-878" title="PART 878—GENERAL AND PLASTIC SURGERY DEVICES">
                                                878
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-880" title="PART 880—GENERAL HOSPITAL AND PERSONAL USE DEVICES">
                                                880
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-882" title="PART 882—NEUROLOGICAL DEVICES">
                                                882
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-884" title="PART 884—OBSTETRICAL AND GYNECOLOGICAL DEVICES">
                                                884
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-886" title="PART 886—OPHTHALMIC DEVICES">
                                                886
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-888" title="PART 888—ORTHOPEDIC DEVICES">
                                                888
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-890" title="PART 890—PHYSICAL MEDICINE DEVICES">
                                                890
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-892" title="PART 892—RADIOLOGY DEVICES">
                                                892
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-898" title="PART 898—PERFORMANCE STANDARD FOR ELECTRODE LEAD WIRES AND PATIENT CABLES">
                                                898
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-1010" title="PART 1010—PERFORMANCE STANDARDS FOR ELECTRONIC PRODUCTS: GENERAL">
                                                1010
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-1020" title="PART 1020—PERFORMANCE STANDARDS FOR IONIZING RADIATION EMITTING PRODUCTS">
                                                1020
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-1030" title="PART 1030—PERFORMANCE STANDARDS FOR MICROWAVE AND RADIO FREQUENCY EMITTING PRODUCTS">
                                                1030
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-1040" title="PART 1040—PERFORMANCE STANDARDS FOR LIGHT-EMITTING PRODUCTS">
                                                1040
                                            </a>, 
                                        
                                            <a href="/cfr/text/21/part-1050" title="">
                                                1050
                                            </a>
</td>
</tr>
</tbody>
</table>
</div>
</div>
</div>
</div>
						
						
					</div>
				</div>
			</div>
			

			<div id="page-bottom" aria-hidden="true">
				<div class="region region-bottom">
					<div id="block-liidfp-2" class="block block-liidfp first last odd">


						<div class="gfs">
							<div id="div-gpt-ad-bottom" data-google-query-id="CNH77Z7C7d8CFURLAQodp9oMpg">
								<script type="text/javascript">
									googletag.cmd.push(function () { googletag.display('div-gpt-ad-bottom'); });
								</script>
							</div>
						</div>
					</div>
				</div>
			</div>

		</div>



		<aside id="supersizeme" class="col-sm-4" aria-label="Sponsor Listings and Toolbox panel">
			
			<div class="block" id="toolbox">

				<h2 class="title toolbox"><span class="glyphicon glyphicon-briefcase"></span> U.S. Code Toolbox
				</h2>

				
<div class="clear-block wexlink">
    <a href="/wex/wex_articles">Law about... Articles from Wex</a>
</div>
<div id="topnlink" class="toolboxlink">
    <a href="/topn">Table of Popular Names</a>
</div>
<div id="ptoalink" class="toolboxlink">
    <a href="/ptoa">Parallel Table of Authorities</a>
</div>
<div id="updatelink" class="toolboxlink">
    <a href=/uscode/about/how-current>How
        current is this?</a>
</div>


				
				<div class="socSep">
					<hr />
				</div>

				<div class="addthis_sharing_toolbox"></div>

				<div class="socSep">
					<hr />
				</div>

				<script type="text/javascript">
					var addthis_config = {
						data_track_addressbar: false,
						data_track_clickback: true,
						publid: 'liiadverts',
						ui_tabindex: 0,
						ui_508_compliant: true
					};
					var addthis_share = {
						url_transforms: {
							shorten: {
								twitter: 'bitly'
							}
						},
						shorteners: {
							bitly: {
								login: 'liicornell',
								apiKey: 'R_75b99d95e1c3033c4dbea23ce04bf5d3'
							}
						},
						passthrough: {
							twitter: {
								via: 'LIICornell'
							}
						}
					};
				</script>

				<script type="text/javascript" src="https://s7.addthis.com/js/300/addthis_widget.js#pubid=liiadverts"
					async="async"></script>

				

			</div>
			

			<div class="block" aria-hidden="true">
				<div class="gfs">
					<div id='div-gpt-ad-top'>
						<script type='text/javascript'>
							googletag.cmd.push(function () { googletag.display('div-gpt-ad-top'); });
						</script>
					</div>
				</div>

			</div>

			<div class="block" aria-hidden="true">
				<div class="gfs">
					<div id='div-gpt-ad-middle'>
						<script type='text/javascript'>
							googletag.cmd.push(function () { googletag.display('div-gpt-ad-middle'); });
						</script>
					</div>
				</div>

			</div>

			
			<div id="block-lii-justia-find-lawyers-sidebar" class="block block-lii last even">
				<div id="block-lii-justia-lawyers" class="block block-lii last even">
					<div class="sidebar">
						<div class="results-sponsored">
							<div data-directive="j-find-a-lawyer" data-crosslink="seemorelawyers"
								data-domain="lawyers.law.cornell.edu">
							</div>
						</div>
					</div>
				</div>
			</div>
			

		</aside>


	</main>

	<footer id="liifooter" class="container-fluid">
		<ul id="liifooternav" class="nav navbar-nav">
			<li class="first">
				<a href="/lii/about/accessibility" class="nav">Accessibility</a>
			</li>
			<li class="first">
				<a href="/lii/about/about_lii" class="nav">About LII</a>
			</li>
			<li>
				<a href="/lii/about/contact_us" class="nav">Contact us</a>
			</li>
			<li>
				<a href="/lii/help_out/sponsor">Advertise here</a>
			</li>
			<li>
				<a href="/lii/help" class="nav">Help</a>
			</li>
			<li>
				<a href="/lii/terms/documentation" class="nav">Terms of use</a>
			</li>
			<li class="last">
				<a href="/lii/terms/privacy_policy" class="nav">Privacy</a>
			</li>
		</ul>
		<ul class="nav navbar-nav navbar-right">
			<li>
				<a href="/" title="LII home page">
					<img width="62" height="43"
						src="https://www.law.cornell.edu/sites/all/themes/liizenboot/images/LII_logo_footer.gif"
						alt="LII logo">
				</a>
			</li>
		</ul>
	</footer>

	<script>
		jQuery(document).ready(function () {
			jQuery("#liisearchlink").click(function () {
				jQuery("#liisearch").toggle('slide');
				jQuery("#liinavbarstuff").toggleClass('searchboxslid');
			});
		});

		jQuery(document).ready(function () {
			jQuery('[data-toggle="tooltip"]').each(function () {
				var $elem = jQuery(this);
				$elem.tooltip({
					html: true,
					container: $elem,
					delay: { hide: 400 }
				});
			});
		});
	</script>

	
	<script type="text/javascript" src="/staticsite_scripts/htmldiff.js"> </script>
	 
	<script type="text/javascript" src="/staticsite_scripts/lii_scriptinator.min.js"> </script>
	 
	
	<script>
		window.addEventListener("load", function () {
			window.cookieconsent.initialise(
				{
					"palette": {
						"popup": {
							"background": "#000"
						}, "button": {
							"background": "#f1d600"
						}
					}
				})
		});
	</script>
	

</body>